Beneficial effects of MGL‐3196 and BAM15 combination in a mouse model of fatty liver disease

脂肪肝 内分泌学 内科学 胰岛素抵抗 医学 2型糖尿病 背景(考古学) 脂肪性肝炎 胰岛素 糖尿病 药理学 生物 疾病 古生物学
作者
Mingyan Zhou,Catherine Li,Frances L. Byrne,Calum S Vancuylenburg,Ellen M. Olzomer,Adam Hargreaves,Lindsay E. Wu,Nicholas Shackel,Webster L. Santos,Kyle L. Hoehn
出处
期刊:Acta Physiologica [Wiley]
卷期号:240 (10): e14217-e14217 被引量:6
标识
DOI:10.1111/apha.14217
摘要

Abstract Background and Aim Metabolic dysfunction‐associated steatohepatitis (MASH) is a metabolic disorder with limited treatment options. The thyroid hormone receptor (THR)‐β agonist resmetirom/MGL‐3196 (MGL) increases liver fat oxidation and has been approved for treating adult MASH. However, over 60% of patients receiving MGL treatment do not achieve MASH resolution. Therefore, we investigated the potential for combination therapy of MGL with the mitochondrial uncoupler BAM15 to improve fatty liver disease outcomes in the GAN mouse model of MASH. Methods C57BL/6J male mice were fed GAN diet for 38 weeks before stratification and randomization to treatments including MGL, BAM15, MGL + BAM15, or no drug control for 8 weeks. Treatments were admixed in diet and mice were pair‐fed to control for drug intake. Treatment effectiveness was assessed by body weight, body composition, energy expenditure, glucose tolerance, tissue lipid content, and histological analyses. Results MGL + BAM15 treatment resulted in better efficacy versus GAN control mice than either monotherapy in the context of energy expenditure, liver fat loss, glucose control, and fatty liver disease activity score. Improvements in ALT, liver mass, and plasma cholesterol were primarily driven by MGL, while improvements in body fat were primarily driven by BAM15. No treatments altered liver fibrosis. Conclusions MGL + BAM15 treatment had overall better efficacy to improve metabolic outcomes in mice fed GAN diet than either monotherapy alone. These data warrant further investigation into combination therapies of THR‐β agonists and mitochondrial uncouplers for the potential treatment of disorders related to fatty liver, obesity, and insulin resistance.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zsq发布了新的文献求助10
1秒前
沉船残骸完成签到 ,获得积分10
1秒前
充电宝的应助被踏实的代曼采纳,获得10
2秒前
3秒前
Singel完成签到,获得积分10
4秒前
丘比特的应助被开朗紫采纳,获得10
6秒前
ww完成签到,获得积分10
7秒前
ws完成签到,获得积分20
7秒前
7秒前
YY发布了新的文献求助10
7秒前
右旋王小二完成签到,获得积分10
8秒前
黎簇完成签到,获得积分10
9秒前
9秒前
丘比特的应助被BINBIN采纳,获得10
9秒前
9秒前
9秒前
9秒前
10秒前
11秒前
12秒前
12秒前
饱满的起眸完成签到,获得积分10
13秒前
13秒前
13秒前
13秒前
13秒前
14秒前
14秒前
14秒前
漫漫发布了新的文献求助10
14秒前
泠漓发布了新的文献求助10
15秒前
小明完成签到 ,获得积分10
15秒前
乌龙茶发布了新的文献求助10
15秒前
Zzzvir发布了新的文献求助10
15秒前
夏成蹊完成签到,获得积分10
15秒前
Lucas的应助被WYT采纳,获得10
15秒前
Renee发布了新的文献求助30
16秒前
天天快乐的应助被孤独白拍采纳,获得20
17秒前
脑洞疼的应助被简单山水采纳,获得10
17秒前
supman的应助被柳亦诚采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181498
求助须知:如何正确求助?哪些是违规求助? 9571421
关于积分的说明 21817968
捐赠科研通 7777967
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479552